Sage Journals: Discover world-class research

Abstract

Spanish

French

OBJECTIVE:

To determine the extent of removal of propafenone by continuous venovenous hemofiltration (CVVH) in a critically ill pediatric patient.

CASE SUMMARY:

A three-year-old white–Japanese girl was admitted to the critical care unit following cardiac surgery. Her postoperative course was complicated by the development of junctional ectopic tachycardia, requiring propafenone; and acute renal failure, which necessitated the use of CVVH. The serum and ultrafiltrate concentrations of propafenone and its 5-hydroxy metabolite were measured to determine both total and CVVH clearance.

CONCLUSIONS:

The data from this case report showed that propafenone was not significantly removed by CVVH. Furthermore, the total clearance of propafenone was not affected by the patient's renal or liver function impairment.

Keywords

propafenone hemofiltration

Get full access to this article

View all access options for this article.

References

Ito

Gow

Verjee

Giesbrecht

Freedom

Koren

. Propafenone for supraventricular ectopic tachycardia in infants and children (abstract). Clin Pharmacol Ther 1994;55:176.

Burgess

Duff

. Hemodialysis removal of propafenone. Pharmacotherapy 1989;9: 331–3.

Hii

Duff

Burgess

. Clinical pharmacokinetics of propafenone. Clin Pharmacokinet 1991;21: 1–10.

Fromm

Botsch

Heinkele

Evers

Kroemer

. Influence of renal function on the steady-state pharmacokinetics of the antiarrhythmic propafenone and its Phase I and Phase II metabolites. Eur J Clin Pharmacol 1995;48: 279–83.

Burgess

Duff

Wilkes

. Propafenone disposition in renal insufficiency and renal failure. J Clin Pharmacol 1989;29: 112–3.

Poirier

Joannides

Geffroy-Josse

Fillastre

Etienne

. Propafenone pharmacokinetics in uremic patients treated by peritoneal dialysis. Clin Nephrol 1992;38: 231–2.

Verjee

Giesbrecht

. An HPLC method for the quantitation of propafenone and its metabolites in pediatric samples. In: Sunshine

, ed. Recent developments in therapeutic drug monitoring and clinical toxicology. New York: Marcel Dekker, 1992: 383–8.

Joy

Matzke

Armstrong

Marx

Zarowitz

. A primer on continuous renal replacement therapy for critically ill patients. Ann Pharmacother 1998;32: 362–75.

Bauman

Schoen

Hoon

. Practical optimisation of antiarrhythmic drug therapy using pharmacokinetic principles. Clin Pharmacokinet 1991;20: 151–66.

10.

Latini

Maggioni

Cavalli

. Therapeutic drug monitoring of antiarrhythmic drugs — rationale and current status. Clin Pharmacokinet 1990;18: 91–103.

Propafenone Disposition during Continuous Venovenous Hemofiltration

Abstract

OBJECTIVE:

CASE SUMMARY:

CONCLUSIONS:

Keywords

Get full access to this article

References